ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,631.22
      0.28%
      US Tech 100
      19,884.80
      0.46%
      Dow Jones
      40,211.72
      0.53%
      Brent Oil
      83.695
      -0.76%
      Bitcoin
      63,801.87
      -1.62%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Relay Therapeutics Inc (RLAY)

      7. Relay Therapeutics Inc (RLAY) News

      Relay Therapeutics Inc

      Relay Therapeutics Inc (RLAY)

      NASDAQ
      8.27
      0.03
      (0.36%)
      Closed July 16 4:00PM
      Delayed by 15 minutes
      8.27
      0.00
      (0.00%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      RLAY News

      Official News Only

      RLAY Discussion

      View Posts
      Monksdream Monksdream 4 months ago
      RLAY under $10
      👍️0
      Monksdream Monksdream 1 year ago
      Using AI to find the next blockbuster drug
      This week, AI chipmaker Nvidia placed their bet — investing $50M into AI drug discovery platform Recursion Pharmaceuticals (NASDAQ:RXRX) — sending its stock up 78%.



      Drugmakers are already benefiting from using AI to discover new drugs. And in the process, AI is speeding up and reducing the cost of the long and expensive drug development process.
      Between 2015 and 2022, the cumulative investment in AI drug development has risen from under $1B to $24.6B.
      In the next decade, Morgan Stanley expects AI will help develop an additional 50 drugs with an extra $50B in sales.
      Following Nvidia’s investment, other AI drug discovery platforms rose on the news, including Exscientia (NASDAQ:EXAI), AbCellera Biologics (NASDAQ:ABCL) and Relay Therapeutics (NASDAQ:RLAY).
      Recursion has five drugs, and Exscientia has three drugs discovered with AI, which are already in human trials. And within the startup sector, AI drug discovery has quickly become one of the hottest markets for investment.
      👍️0

      Your Recent History

      NASDAQ
      RLAY
      Relay Therapeutics
      Delayed Upgrade Clock